DDR (Barcelona, ES; London, UK) and Kinesys Consulting (Glasgow & London, UK) are pleased to announce that they have joined forces to create a unique platform of EU regulatory and scientific experts, EMA Solutions, with the aim of preparing and helping Applicants for interactions
Delphine is joining Kinesys Consulting as Associate Director Regulatory Affairs. She was most recently at Amgen, where she spent 10 years working in Global Regulatory Affairs. During her time at Amgen, Delphine worked in a number of roles including regulatory
Join regulatory and industry leaders at the only Europe-wide healthcare regulatory affairs conference with comprehensive programmes covering medical technologies, human and animal medicines –held by TOPRA in partnership this year with the Swedish MPA in Stockholm from 1–3 October 2018. Get important updates
Our Associate Director, Dr Graeme Deuchar, will be presenting an “Overview and Real World Experience of MHRA’s PIM Designation / Early Access to Medicines Scheme” at the next TOPRA in Scotland meeting. The meeting will be held on 27 September
Kinesys Consulting Ltd is pleased to announce that the European Commission, acting on the positive recommendation from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to Soligenix’ recombinant modified ricin toxin A-chain